Talaris Therapeutics to Participate at the 5th Annual Evercore ISI HealthCONx Conference

Rhea-AI Summary

Talaris Therapeutics (Nasdaq: TALS) announced that CEO Scott Requadt will participate in a fireside chat at the 5th Annual Evercore ISI HealthCONx Conference on November 29, 2022, at 4:20 PM ET. This virtual event will provide insights into Talaris's innovative cell therapy advancements aimed at enhancing solid organ transplantation and addressing severe immune and blood disorders. A live webcast will be accessible on Talaris's investor website, remaining archived for 30 days post-event.

BOSTON and LOUISVILLE, Ky., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders, today announced that Scott Requadt, Chief Executive Officer of Talaris, will participate in a fireside chat at the 5th Annual Evercore ISI HealthCONx Conference being held virtually on Tuesday, November 29, 2022 at 4:20 PM ET.

A live webcast of the presentation will be available on the investors section of the Talaris website at www.talaristx.com. After the live webcast, the event will remain archived on the Talaris website for 30 days.

About Talaris Therapeutics
Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders. Talaris maintains corporate offices in Boston, MA, its cell processing facility in Louisville, KY, and additional research operations in Houston, TX.

Media Contact
Lisa Raffensperger
Ten Bridge Communications
lisa@tenbridgecommunications.com
(617) 903-8783

Investor Contact
Chris Brinzey
ICR Westwicke
chris.brinzey@westwicke.com
(339) 970-2843

FAQ

When will Talaris CEO Scott Requadt speak at the HealthCONx Conference?

Scott Requadt will participate in a fireside chat on November 29, 2022, at 4:20 PM ET.

Where can I watch the Talaris Therapeutics presentation?

The presentation will be available via live webcast on the Talaris website and will be archived for 30 days.

What is the focus of Talaris Therapeutics?

Talaris Therapeutics is focused on developing cell therapies for solid organ transplantation and severe immune and blood disorders.

What is the stock symbol for Talaris Therapeutics?

The stock symbol for Talaris Therapeutics is TALS.

What is the date of the 5th Annual Evercore ISI HealthCONx Conference?

The conference will be held virtually on November 29, 2022.